Next Step Psychiatry offers FDA-approved SPRAVATO™ treatment at our Lilburn office. Our modern psychiatric practice, located at 4652 Lawrenceville Hwy STE 104, provides this innovative treatment option for adults with treatment-resistant depression with the convenience of same-day appointments and minimal wait times.
Our board-certified providers, Fathima Chowdhury, PA-C, and Khadeja Chowdhury, PA-C, bring extensive experience in administering SPRAVATO™ treatment. If you've tried multiple antidepressants without adequate relief, SPRAVATO™ might be the breakthrough treatment you need.
SPRAVATO™ (esketamine) is an FDA-approved nasal spray for treatment-resistant depression:
We offer comprehensive SPRAVATO™ treatment services:
Your SPRAVATO™ treatment journey includes:
Initial Phase:
Treatment Sessions:
Ongoing Care:
Our highly qualified team brings extensive experience in SPRAVATO™ treatment:
Fathima Chowdhury, PA-C
Khadeja Chowdhury, PA-C
Our SPRAVATO™ treatment center features:
We make SPRAVATO™ treatment accessible:
Your SPRAVATO™ treatment experience includes:
Typical SPRAVATO™ treatment schedule:
Starting your SPRAVATO™ treatment is simple:
Our Lilburn office is conveniently located:
Take the first step toward relief from treatment-resistant depression. Contact Next Step Psychiatry today at 678-437-1659 to learn more about SPRAVATO™ treatment. Our Lilburn office offers comprehensive care in a supportive, professional environment.
SPRAVATO™ (esketamine) is an FDA-approved nasal spray for treatment-resistant depression. It works differently from traditional antidepressants and is used alongside oral antidepressants. The treatment is administered under medical supervision at our Lilburn office, with potential for rapid symptom improvement in treatment-resistant depression.
SPRAVATO™ is administered in our comfortable, private treatment rooms under medical supervision. Each session includes the nasal spray administration followed by a 2-hour monitoring period where we track your response and vital signs. Our board-certified providers oversee the entire process to ensure safety and effectiveness.
The treatment begins with an Induction Phase (Weeks 1-4) requiring two treatments per week. This is followed by a Maintenance Phase with weekly or bi-weekly treatments, customized based on your response. Each session includes administration and a 2-hour monitoring period.
Yes, SPRAVATO™ treatment is covered by most major insurance plans, including Medicare and Medicaid. We provide insurance verification services and prior authorization assistance. Our team will help verify your coverage and explain any out-of-pocket costs before beginning treatment.
SPRAVATO™ is designed for adults with treatment-resistant depression who have tried multiple antidepressants without adequate relief. Our providers will conduct a comprehensive evaluation to determine your eligibility, reviewing your medical history and previous treatments to ensure SPRAVATO™ is appropriate for you.
Your first treatment includes a pre-treatment assessment, comfortable administration of the nasal spray, and a 2-hour monitoring period in our relaxing treatment room. Our medical team will monitor your vital signs and response throughout the session, ensuring your safety and comfort.
Our SPRAVATO™ treatment is provided by board-certified Physician Assistants Fathima Chowdhury and Khadeja Chowdhury. They have extensive experience in administering SPRAVATO™ and managing treatment-resistant depression, ensuring safe and effective treatment delivery.
Getting started is simple: Call us at 678-437-1659 to schedule your initial consultation. We'll conduct an eligibility assessment, verify your insurance coverage, and create a personalized treatment plan. Our office is located at 4652 Lawrenceville Hwy STE 104, Lilburn, GA.